Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 925 | 0 | 0 | 0 | 0 |
| Gross Profit | 925 | N/A | N/A | N/A | N/A |
| Operating Expenses | 83,530 | 55,583 | 56,517 | 60,698 | 33,728 |
| Operating Income | -82,605 | -55,583 | -56,517 | -60,698 | -33,728 |
| Interest Expense | 12 | 12 | 2 | 0 | 0 |
| Other Income | 7,473 | 19,278 | 1,330 | 6 | 451 |
| Pre-tax Income | -75,144 | -36,317 | -55,189 | -60,692 | -33,277 |
| Net Income Continuous | -75,144 | -36,317 | -55,189 | -60,692 | -33,277 |
| Net Income | $-75,144 | $-36,317 | $-55,189 | $-60,692 | $-33,277 |
| EPS Basic Total Ops | -4.28 | -73.82 | -139.72 | -22.00 | -12.80 |
| EPS Basic Continuous Ops | -4.28 | -73.82 | -139.72 | -22.05 | -12.84 |
| EPS Diluted Total Ops | -4.28 | -73.82 | -139.72 | -22.00 | -12.80 |
| EPS Diluted Continuous Ops | -4.28 | -7.80 | -139.72 | -22.05 | -12.84 |
| EPS Diluted Before Non-Recurring Items | -4.28 | N/A | -20.80 | -22.00 | -15.80 |
| EBITDA(a) | $-81,777 | $-52,391 | $-53,317 | $-58,421 | $-31,907 |